A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma

This study assessed the safety and preliminary efficacy of escalated dose subcutaneous alemtuzumab in combination with rituximab in chronic lymphocytic leukemia. Twenty-eight patients with relapsed refractory chronic lymphocytic leukemia were treated on four dosing cohorts of weekly rituximab at 375...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Brown, Jennifer R., Messmer, Bradley, Werner, Lillian, Davids, Matthew S., Mikler, Evgeny, Supko, Jeffrey G., Fisher, David C., LaCasce, Ann S., Armand, Philippe, Jacobsen, Eric, Dalton, Virginia, Tesar, Bethany, Fernandes, Stacey M., McDonough, Sean, Ritz, Jerome, Rassenti, Laura, Kipps, Thomas J., Neuberg, Donna, Freedman, Arnold S.
Format: Artigo
Sprog:Inglês
Udgivet: Ferrata Storti Foundation 2013
Fag:
Original Articles and Brief Reports
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3669454/
https://ncbi.nlm.nih.gov/pubmed/23645694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.086207
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker